- Action: Inhibits leukotriene (LTD4)
formation; leukotrienes exert their effects by increasing neutrophil,
eosinophil migration; aggregation of neutrophils, monocytes; smooth muscle
contraction, capillary permeability; these actions further lead to
bronchoconstriction, inflammation, edema
- Uses: Chronic asthma
- Dosage and routes:
- Asthma
- Adult and child
15 yr: PO 10 mg qd pm
- Child 6-14 yr: PO 5 mg chew tab qd pm
- Available Forms: Tabs 10 mg; tabs,
chew 5 mg
- Side effects/adverse reactions:
CNS: Dizziness, fatigue, headache
GI: Abdominal pain, dyspepsia, LFTs abnormalities
INTEG: Rash
MS: Asthenia
RESP: Influenza, cough, nasal congestion
- Contraindications: Hypersensitivity
- Precautions: Acute attacks of asthma, alcohol
consumption, pregnancy (B), lactation, child <6 yr, aspirin sensitivity
- Pharmacokinetics: Rapidly absorbed, peak 3-4
hr, half-life 2.7-5.5 hr; protein binding 99%; metabolized by liver, excreted
via bile
- Interactions:
- Decreased montelukast levels: phenobarbital, rifampin
|